Yahoo · Nov 3, 2026
What Twist MRD Express Could Mean For Twist Bioscience Stock Twist Bioscience (TWST) just rolled out Twist MRD Express, a customizable panel platform for molecular residual disease research that targets cancer-focused labs needing faster, more personalized test development at scale. Twist Bioscience has had a sharp pullback, with the share price down 15.54% over the last day and 31.61% over the past month. However, the 90 day share price return of 29.76% and year to date gain of 298.39% keep...
Yahoo · Nov 3, 2026
Twist Bioscience (NasdaqGS:TWST) introduced Twist MRD Express, a new personalized molecular residual disease panel service for cancer research. The offering focuses on rapid production of custom MRD detection panels intended for use in oncology and liquid biopsy studies. Twist MRD Express targets researchers seeking scalable workflows to monitor cancer recurrence using individualized genetic signatures. There is more to Twist Bioscience than the new Twist MRD Express launch for personalized...
Yahoo · Nov 2, 2026
The fund sold $292.1 million more than it bought, with 1,876 positions decreased and one increased.
Yahoo · Nov 2, 2026
The fund bought $33.6 million of Twist Bioscience and $13.8 million of SpaceX, while exiting its Alphabet Class A stake for $250.5 million.
